- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04299958
Observational Prospective Study on the Presence of Typical Migraine Features in Nummular Headache Patients: The Numamig Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background:
Nummular headache (NH) is a primary headache included in the International Classification of Headache Disorders (ICHD) characterized by a well delimited superficial pain, with sharp border, felt in a rounded or elliptical 1-6 centimeters area. Pain might be continuous or intermittent. The key feature of nummular headache is the fixed superficial topography.
The real nature of this condition is still a matter of controversial. Some authors defend it as a specific condition with a particular pathophysiology; whereas others consider that it might be a localized form of migraine with a shared phenotype and pathophysiology.
Among the arguments that defend its existence as a differentiated entity we include: the older age of onset, the fixed and localized pain without pain in other territories, presence of trophic changes, the localized abnormality in pressure pain threshold determination, the description of secondary cases, the description of posttraumatic cases or the specific therapeutic response.
On the other hand, in some cases hypersensitivity to stimuli has been described, other typical migrainous symptoms such as nausea or vomiting might be present, and some patients respond to triptans or other migraine prophylactics.
Information is scarce about the presence of prodromes, postdromes or family history of migraine. Moreover, little is known about NH pathophysiology, some studies suggest an impairment in superficial sensory fibers because a localized alteration of pressure-pain threshold. No imaging or laboratory studies have been done so far.
This is a proof of concept study. The aim is to analyze if patients with a definite NH diagnosis according to ICHD present any shared epidemiological, clinical or therapeutical features with migraine.
Hypothesis:
Nummular headache might be a specific condition or it might share migraine biologic features. The detailed description of it might help to clarify whether if NH is a single entity or a focal presentation form of migraine.
Objective:
To describe the presence of typical features of migraine in a cohort of NH patients, including family history, epidemiology, clinical description, presence of prodromes or postdromes and response to treatment.
Methods:
The study has an observational analytic design following the Strengthening the Reporting of Observational in Epidemiology (STROBE) guidelines. Patients with definite nummular headache diagnosis according to The International Classification of Headache Disorders1 will be invited to participate. The study will be conducted in the Headache Unit of Hospital Clinico Universitario de Valladolid, a third level hospital sited in Valladolid, with a reference population of 280.000 people.
Intervention:
The study will be divided into different sections:
- Family history of headache and in particular, migraine.
- Epidemiology of NH patients.
- Clinical phenotype and pattern of the headache.
- Associated symptoms, presence of prodromes and postdromes.
- Physical examination.
- Prior treatment use, tolerability and response.
Selection of participants:
Recruitment will be recruited by a non-probabilistic sampling method by convenience and by formal invitation if they are included in the clinical registry of the Headache Unit of the Hospital Clinico Universitario de Valladolid.
In the first visit participants will be examined by a neurologist with experience in headache disorders and NH diagnosis will be reviewed. Patients will be invited to participate into the study and they will provide and sign informed consent form. They will be instructed and trained to complete the prospective headache diary during 14 days. A follow up visit will be done within 15 to 30 days to review the data and analyze possible sources of bias.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Valladolid, Spain, 47003
- Hospital Clinico Universitario Valladolid
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Diagnosis of Nummular Headache (NH) according to the International Classification of Headache Disorders, 3rd version (ICHD-3).
- More than 3 months of NH evolution.
- No better accounted for by another ICHD-3 diagnosis.
- Older than 18 years.
- Capable of prospectively register headache characteristics in a diary.
- Ability to provide informed consent form.
Exclusion Criteria:
- Other primary or secondary headache, except for infrequent tension-type headache or medication overuse headache.
- Major psychiatric disorders.
- Alcoholism or drug use.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Family history of migraine
Time Frame: Through study completion, an average of 1 month
|
To assess family history of migraine headache in nummular patients.
We will build family tree up to 3 generations and we will ask patients to complete it by questioning their relatives.
|
Through study completion, an average of 1 month
|
|
Epidemiological pattern
Time Frame: Through study completion, an average of 1 month
|
To determine age of onset, age when they were diagnosed, temporal pattern and frequency of headache.
|
Through study completion, an average of 1 month
|
|
Clinical phenotype
Time Frame: Through study completion, an average of 1 month
|
To assess the clinical characteristics of nummular headache, analyzing the presence of typical features of migraine.
Patients will complete a prospective headache diary for 15 days.
|
Through study completion, an average of 1 month
|
|
Presence of associated symptoms
Time Frame: Through study completion, an average of 1 month
|
To assess the presence of symptoms such as nausea, vomiting, dizziness during the headache episodes.
|
Through study completion, an average of 1 month
|
|
Presence of prodromes
Time Frame: Through study completion, an average of 1 month
|
To assess the presence of typical migraine prodromes before the headache episodes.
|
Through study completion, an average of 1 month
|
|
Presence of postdromes
Time Frame: Through study completion, an average of 1 month
|
To assess the presence of typical migraine postdromes after the headache episode.
|
Through study completion, an average of 1 month
|
|
Presence of sensory disturbances
Time Frame: Through study completion, an average of 1 month
|
To evaluate the presence of sensory changes such as hypoesthesia, hyperalgesia or allodinia upon examination.
|
Through study completion, an average of 1 month
|
|
Response to acute treatment
Time Frame: Through study completion, an average of 1 month
|
To describe response to prior acute medications.
|
Through study completion, an average of 1 month
|
|
Response to prophylactic treatment
Time Frame: Through study completion, an average of 1 month
|
To assess response to prior prophylactic treatments.
|
Through study completion, an average of 1 month
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202. No abstract available.
- Pareja JA, Caminero AB, Serra J, Barriga FJ, Baron M, Dobato JL, Vela L, Sanchez del Rio M. Numular headache: a coin-shaped cephalgia. Neurology. 2002 Jun 11;58(11):1678-9. doi: 10.1212/wnl.58.11.1678.
- Trigo J, Garcia-Azorin D, Martinez Pias E, Sierra A, Chavarria A, Guerrero AL. Clinical characteristics of nummular headache and differentiation between spontaneous and posttraumatic variant: an observational study. J Headache Pain. 2019 Apr 8;20(1):34. doi: 10.1186/s10194-019-0981-4.
- Garcia-Azorin D, Trigo-Lopez J, Sierra A, Blanco-Garcia L, Martinez-Pias E, Martinez B, Talavera B, Guerrero AL. Observational, open-label, non-randomized study on the efficacy of onabotulinumtoxinA in the treatment of nummular headache: The pre-numabot study. Cephalalgia. 2019 Dec;39(14):1818-1826. doi: 10.1177/0333102419863023. Epub 2019 Jul 4.
- Cuadrado ML, Lopez-Ruiz P, Guerrero AL. Nummular headache: an update and future prospects. Expert Rev Neurother. 2018 Jan;18(1):9-19. doi: 10.1080/14737175.2018.1401925. Epub 2017 Nov 9.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PI 20-1638
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Migraine
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingMigraine | Migraine Headache | Migraine Without Aura | Migraine with Aura | Chronic Migraine, Headache | Episodic Migraine | Chronic Migraine Headache | Headache (Migraine) | Episodic Migraine HeadacheSpain
-
Austrian Migraine Registry CollaborationMedical University of Vienna; Medical University Innsbruck; Austrian Headache...RecruitingMigraine | Chronic Migraine | Migraine Without Aura | Migraine With Aura | Episodic MigraineAustria
-
Brigham and Women's HospitalNot yet recruitingMigraine Disorders | Migraine Without Aura | Migraine With Aura | Episodic MigraineUnited States
-
CoolTech LLCTerminatedMigraine | Migraine Without Aura | Migraine With Aura | Episodic MigraineUnited States
-
Harvard University Faculty of MedicineBrigham and Women's Hospital; Palmer Center for Chiropractic Research (PCCR)CompletedMigraine | Migraine Disorders | Migraine Without Aura | Migraine With Aura | Migraine, ClassicUnited States
-
Tonix Pharmaceuticals, Inc.PremierCompletedChronic Migraine | Chronic Migraine, Headache | Chronic Migraine Without Aura | Aura MigraineUnited States
-
Notre-Dame Hospital, Montreal, Quebec, CanadaAllerganCompletedChronic Migraine | Migraine Without Aura | Migraine With AuraCanada
-
Glostrup University Hospital, CopenhagenUnknownChronic Migraine | Migraine Without Aura | Migraine With AuraDenmark
-
University of AlbertaCanadian Institutes of Health Research (CIHR)CompletedMigraine Without Aura | Migraine With Aura | Probable MigraineCanada
-
Ariston Pharmaceuticals, Inc.UnknownMigraine | Migraine Disorders | Migraine Headache | Migraine Without Aura | Migraine With AuraFinland, Netherlands, United Kingdom
Clinical Trials on Patient diary
-
The Christie NHS Foundation TrustCompletedCancerUnited Kingdom
-
Ohio State University Comprehensive Cancer CenterCompletedSkin Cancer | Gastrointestinal Cancer | Neuroendocrine CarcinomaUnited States
-
Medical University of ViennaCompleted
-
AstraZenecaCompleted
-
Michigan State UniversityKenyan Diabetes Management & Information Centre (DMI)CompletedType 1 DiabetesKenya
-
Augusta UniversityRecruiting
-
Augusta UniversityRecruitingConstipation | Diarrhea | Bloating | Distension | GasUnited States
-
Yeditepe UniversityBahçeşehir UniversityCompleted
-
Unidade Local de Saúde de Matosinhos, EPERecruitingMigraine Disorders | Episodic MigrainePortugal
-
Marmara UniversityCompletedCardiovascular SurgeryTurkey